Skip to main content

Table 1 Description of the eleven patients with unexpected positive intraoperative culture

From: Antibiotic therapy alone does not have a high success rate in cases of unexpected positive cultures in intraoperative samples from hip and knee prosthesis revision

Pat.

Gen-der

BMI

ASA

CCI

Joint

Histo-ry Joint

Number previous opera-tions at the joint including arthropl.

CRP Pre-biopsy (mg/L)

WBC count in synovia

(cells/μL)

Micro-biology Biopsy

Histology Biopsy

ICM-Score pre-op

Micro-biology Revision

Histo-logy Re-vision

ICM-Score after revi-sion

Antibiotic Therapy

Re-infection after months

1

male

25.4

2

0

TKA

Loose-ning after 6 years

1

21

1360

neg.

neg.

2

Staph. hominis (3/5)

neg.

major + 2

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

36 months with Staph. hominis

2

fem.

28.1

2

0

TKA

Revi-sion after 3 years because of arthro-fibrosis

3

<  5

800

neg.

neg.

0

Staph. epidermidis (3/5)

Staph. hominis (1/5)

neg.

major

Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

no

3

male

26.3

2

0

TKA

Loose-ning after 10 years

1

<  5

630

neg.

neg.

0

Staph. hominis (2/5)

Staph. epidermidis (1/5)

neg.

major

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

14 months with Staph. hominis

4

fem

30.8

3

4

TKA

Loose-ning after 8 years

2

16

1000

neg.

neg.

2

Staph. epidermidis (2/5)

neg.

major

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

no

5

fem.

25.1

3

1

THA

Loose-ning after 10 years

2

<  5

360

neg.

neg.

0

Staph. epidermidis (4/5)

neg.

major

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

no

6

fem.

32.9

3

6

THA

Loose-ning after 4 years

1

11

860

Brevi-bacillus brevis (1/5)

neg.

2

Staph. epidermidis (3/5)

positive

major + 5

Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

12 months with Staph. epidermi-dis

7

male

26.5

1

0

THA

Loose-ning after 10 years

1

<  5

640

neg.

neg.

0

Staph. caprae (5/5)

neg.

major

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

no

8

male

21.9

2

0

THA

Loose-ning after 10 years

2

<  5

1200

neg.

neg.

0

Staph. capitis (5/5)

2 Cutibac-terium agnes (5/5)

positive

major + 3

Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

14 months with Staph. capitis

9

male

28.9

2

2

THA

Loose-ning after 9 years

1

<  5

880

neg.

neg.

0

Staph. epidermidis (5/5)

neg.

major

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

no

10

male

23.5

2

1

THA

Stem loose-ning after 6 years

2

<  5

1100

neg.

neg.

0

Staph. epidermidis (4/5)

Staph. capitits (2/5)

neg.

major

Flucloxacillin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

no

11

fem.

29.6

2

1

THA

Loose-ning after 8 years

5

<  5

480

neg.

neg.

0

Staph. epidermidis (2/5)

Cutibac-terium agnes (2/5)

neg.

major

Vancomycin + Rifampicin 2 weeks then Levofloxacin + Rifampicin 4 weeks

4 months with Staph. epidermidis

  1. Pat. Patient, fem. Female, BMI Body mass index, ASA Grading of patients for surgical procedures of the American Society of Anesthesiologists [29], CCI Charlson Comorbidity Index [30], WBC White blood cell count., y Years, neg. Negative